Cumberland Pharmaceuticals (CPIX) Operating Expenses (2010 - 2026)

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Cumberland Pharmaceuticals was $40.9 million, up 10.6% year-over-year; for FY2025, it came in at $47.31 million, up 6.8% from FY2024.

• Annual Operating Expenses shows a five-year compound annual growth rate of 1.5% (FY2020 to FY2025).
• In prior years, Cumberland Pharmaceuticals' Operating Expenses was $44.3 million in FY2024 (-9.8%), $49.11 million in FY2023 (+2.9%), $47.72 million in FY2022 (+9.3%) and $43.66 million in FY2021 (-0.4%).
• The Q2 2026 figure stands as the lowest quarterly Operating Expenses in data going back to Q2 2010.
• On a year-over-year basis, Operating Expenses increased in three of the last eight quarters, with an average decline of 8.5%.
• The strongest year-over-year quarter for Operating Expenses in the past five years was Q4 2023, with growth of 36.2%; the weakest was Q2 2025, with a decline of 67.8%.
• According to Business Quant data, Operating Expenses for the three prior quarters was $12.26 million (Q1 2026), $15.05 million (Q4 2025) and $10.26 million (Q3 2025).